TipRanks
Mankind Pharma Ltd. (IN:MANKIND)
:MANKIND
India Market
Want to see IN:MANKIND full AI Analyst Report?

Mankind Pharma Ltd. (MANKIND) Ratios

15 Followers

Mankind Pharma Ltd. Ratios

IN:MANKIND's free cash flow for Q1 2027 was ₹0.44. For the 2027 fiscal year, IN:MANKIND's free cash flow was decreased by ₹ and operating cash flow was ₹0.22. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
0.00 1.07 1.23 3.10 2.32
Quick Ratio
0.00 0.74 0.86 2.37 1.52
Cash Ratio
0.00 0.07 0.10 0.18 0.16
Solvency Ratio
-0.18 0.24 0.20 0.97 0.78
Operating Cash Flow Ratio
0.00 0.39 0.43 1.02 0.96
Short-Term Operating Cash Flow Coverage
0.00 0.74 0.82 12.58 12.79
Net Current Asset Value
₹ 165.61B₹ -45.64B₹ -62.03B₹ 41.81B₹ 22.61B
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.22 0.31 0.02 0.02
Debt-to-Equity Ratio
0.00 0.39 0.59 0.02 0.02
Debt-to-Capital Ratio
0.00 0.28 0.37 0.02 0.02
Long-Term Debt-to-Capital Ratio
0.00 0.15 0.28 <0.01 <0.01
Financial Leverage Ratio
0.00 1.72 1.94 1.28 1.31
Debt Service Coverage Ratio
6.11 0.85 0.91 11.82 9.18
Interest Coverage Ratio
5.07 4.27 6.17 146.90 38.53
Debt to Market Cap
0.00 0.08 0.09 <0.01 <0.01
Interest Debt Per Share
14.02 168.42 220.41 5.87 5.30
Net Debt to EBITDA
0.00 1.51 2.24 -0.06 -0.07
Profitability Margins
Gross Profit Margin
50.75%43.11%70.76%67.87%38.76%
EBIT Margin
21.29%20.82%24.06%23.33%19.45%
EBITDA Margin
27.35%27.02%29.15%27.18%23.18%
Operating Profit Margin
19.91%19.13%20.61%39.54%18.51%
Pretax Profit Margin
17.38%16.34%20.61%23.22%19.12%
Net Profit Margin
13.86%13.40%16.31%18.51%14.66%
Continuous Operations Profit Margin
14.03%13.57%16.44%18.79%14.98%
Net Income Per EBT
79.74%82.01%79.12%79.73%76.70%
EBT Per EBIT
87.32%85.41%100.02%58.71%103.29%
Return on Assets (ROA)
0.00%6.81%7.17%15.99%13.19%
Return on Equity (ROE)
12.83%11.74%13.89%20.43%17.24%
Return on Capital Employed (ROCE)
0.00%12.66%11.39%41.52%20.61%
Return on Invested Capital (ROIC)
0.00%9.08%8.00%33.01%15.86%
Return on Tangible Assets
0.00%16.01%17.87%18.61%16.15%
Earnings Yield
2.09%2.31%2.00%2.07%2.25%
Efficiency Ratios
Receivables Turnover
0.00 8.23 7.94 12.18 14.43
Payables Turnover
0.00 6.06 3.15 3.01 6.89
Inventory Turnover
0.00 3.79 1.70 2.14 3.57
Fixed Asset Turnover
0.00 3.95 3.75 3.29 2.84
Asset Turnover
0.00 0.51 0.44 0.86 0.90
Working Capital Turnover Ratio
65.95 16.12 4.23 2.99 4.12
Cash Conversion Cycle
0.00 80.42 144.20 79.47 74.47
Days of Sales Outstanding
0.00 44.32 46.00 29.96 25.29
Days of Inventory Outstanding
0.00 96.37 214.11 170.75 102.15
Days of Payables Outstanding
0.00 60.28 115.91 121.24 52.97
Operating Cycle
0.00 140.69 260.11 200.71 127.44
Cash Flow Ratios
Operating Cash Flow Per Share
39.65 60.96 59.64 53.73 44.55
Free Cash Flow Per Share
33.08 45.79 48.25 44.19 23.78
CapEx Per Share
6.57 15.17 11.39 9.54 20.77
Free Cash Flow to Operating Cash Flow
0.83 0.75 0.81 0.82 0.53
Dividend Paid and CapEx Coverage Ratio
5.24 3.77 5.24 5.63 2.14
Capital Expenditure Coverage Ratio
6.04 4.02 5.24 5.63 2.14
Operating Cash Flow Coverage Ratio
0.00 0.40 0.28 10.39 10.47
Operating Cash Flow to Sales Ratio
0.11 0.18 0.20 0.21 0.20
Free Cash Flow Yield
1.40%2.28%1.96%1.91%1.67%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
47.86 43.28 49.99 48.41 44.45
Price-to-Sales (P/S) Ratio
6.64 5.80 8.15 8.96 6.52
Price-to-Book (P/B) Ratio
5.90 5.08 6.94 9.89 7.66
Price-to-Free Cash Flow (P/FCF) Ratio
71.63 43.81 50.94 52.32 59.82
Price-to-Operating Cash Flow Ratio
59.74 32.91 41.22 43.03 31.93
Price-to-Earnings Growth (PEG) Ratio
7.98 -7.55 16.81 0.98 -4.21
Enterprise Value Multiple
24.27 22.97 30.19 32.90 28.05
Enterprise Value
978.18B 886.11B 1.07T 924.37B 568.41B
EV to EBITDA
24.27 22.97 30.19 32.90 28.05
EV to Sales
6.64 6.21 8.80 8.94 6.50
EV to Free Cash Flow
71.63 46.89 55.02 52.22 59.67
EV to Operating Cash Flow
59.77 35.22 44.51 42.95 31.85
Tangible Book Value Per Share
401.16 10.35 -50.61 197.03 146.54
Shareholders’ Equity Per Share
401.16 394.95 354.18 233.73 185.61
Tax and Other Ratios
Effective Tax Rate
0.19 0.17 0.20 0.19 0.22
Revenue Per Share
356.99 345.95 301.67 257.99 218.25
Net Income Per Share
49.48 46.35 49.20 47.75 32.00
Tax Burden
0.80 0.82 0.79 0.80 0.77
Interest Burden
0.82 0.78 0.86 1.00 0.98
Research & Development to Revenue
0.00 0.00 0.00 <0.01 <0.01
SG&A to Revenue
0.24 0.24 0.28 0.22 0.13
Stock-Based Compensation to Revenue
<0.01 0.00 <0.01 <0.01 <0.01
Income Quality
0.66 1.32 1.21 1.13 1.39
Currency in INR